LANGHORNE, Pa., Oct. 04, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced that Adam Levy, CEO, will participate at the Dawson James Securities 7th Annual Small Cap Growth Conference in Jupiter, Florida and the LD Micro Main Event XV Conference in Los Angeles, California in October 2022.
Dawson James Securities 7th Annual Small Cap Growth Conference
Date: Wednesday, October 12th, 2022
Time: Wednesday, October 12th at 5:00 P.M. ET
Location: Wyndham Grand Hotel at Jupiter, Florida
To attend, please contact your Dawson James representative.
LD Micro Main Event XV
Date: Tuesday, October 25th – Wednesday, October 27th, 2022
Time: Wednesday, October 26th at 8:30 A.M. PT
Location: Luxe Sunset Boulevard Hotel at Los Angeles, California
To attend, register here.
If you would like to book 1x1 investor meetings with NEXGEL, please contact your Dawson James representative, LD Micro representative or send an email to NEXGEL@kcsa.com.
About NEXGEL, INC.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
valter@kcsa.com
Media Contacts:
Raquel Cona
KCSA Strategic Communications
212.896.1204
rcona@kcsa.com
